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Background: Fatty acid modifying enzyme (FAME) has been shown to modify free fatty acids to alleviate their
bactericidal effect by esterifying fatty acids to cholesterol or alcohols. Although it has been shown in previous
studies that FAME is required for Staphylococcus aureus survival in skin abscesses, FAME is poorly studied compared
to other virulence factors. FAME activity had also been detected in coagulase-negative staphylococci (CNS).
However, FAME activity was only surveyed after a bacterial culture was grown for 24 h. Therefore if FAME activity
was earlier in the growth phase, it would not have been detected by the assay and those strains would have been
labeled as FAME negative.
Results: Fifty CNS bovine mastitis isolates and several S. aureus, Escherichia coli, and Streptococcus uberis strains were
assayed for FAME activity over 24 h. FAME activity was detected in 54% of CNS and 80% S. aureus strains surveyed
but none in E. coli or S. uberis. While some CNS strains produced FAME activity comparable to the lab strain of
S. aureus, the pattern of FAME activity varied among strains and across species of staphylococci. All CNS that
produced FAME activity also exhibited lipase activity. Lipase activity relative to colony forming units of these CNS
decreased over the 24 h growth period. No relationship was observed between somatic cell count in the milk and
FAME activity in CNS.
Conclusions: Some staphylococcal species surveyed produced FAME activity, but E. coli and S. uberis strains did
not. All FAME producing CNS exhibited lipase activity which may indicate that both these enzymes work in concert
to alter fatty acids in the bacterial environment.
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Fatty acid modifying enzyme (FAME) was first described
by Mortensen et al. [1] while studying abscesses caused
by Staphylococcus aureus. It was found that culture fil-
trates of S. aureus contained an extracellular enzyme
that counteracted the bactericidal activity of lipids within
abscesses. When fatty acid samples were incubated with
FAME in the presence of ethanol, ethyl esters were pro-
duced. The FAME enzyme acts by esterifying free fatty
acids to short chain primary alcohols and cholesterol, with
cholesterol being the preferred substrate [1] (Figure 1).* Correspondence: mmcguire@uidaho.edu
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reproduction in any medium, provided the orWhile FAME activity can be detected experimentally,
the FAME protein and its corresponding gene have yet
to be identified.
In an abscess, microbicidal fatty acids are part of the
first line of defense for the host against invading patho-
gens [2]. Staphylococcal FAME, however, is inhibited by
glycerides and it is thought that to alleviate this inhib-
ition, S. aureus also produces lipase which liberates the
free fatty acids from the glyceride backbone so that
FAME can further esterify the free fatty acids [3]. Previ-
ous studies have shown that about 80% of the staphylo-
coccal strains that produce lipase also produce FAME.
Strains that did not produce both of these enzymes were
more sensitive to free fatty acids. Long and colleagues
[4] speculated that survival in abscesses and pathogen-
esis would require these two enzymes.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Esterification of fatty acids by fatty acid modifying enzyme (FAME). Staphylococci (open circles) colonize the host and block the
bactericidal effects of fatty acids (open bolt) by secreting FAME (solid balloons) which esterifies fatty acids to alcohol esters.
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number of other staphylococci including coagulase-
negative staphylococci (CNS). However, FAME activity
was only surveyed after CNS were grown for 24 h [4]
and in one strain of S. epidermidis for up to 12 h [5].
Therefore if FAME activity occurred earlier in the
growth phase but the enzyme producing this activity
was degraded before the assayed time point, it would
not have been detected by the assay and those strains
would have been labeled as FAME negative. S. aureus
strains that had been previously studied included the lab
strain S. aureus RN6390 and clinical isolates found in
intraperitoneal abscesses [1,2]. However, staphylococci
clinically important in bovine mastitis have yet to be
characterized for FAME activity. We hypothesized that
FAME activity is dependent on staphylococcal strain and
is related to virulence.
Results
Fifty CNS strains isolated from bovine milk were assayed
for FAME activity over 24 h. Bacterial growth assessed
by optical density (OD) and colony forming units (CFU)
were found to be similar in all strains within species. In
our growth conditions, cultures reached stationary phase
after 8–12 h. FAME activity was detected in at least one
strain of each CNS species except for Staphylococcusequorum, Staphylococcus gallinarum, and Staphylococcus
sciuri. Out of the 50 CNS strains surveyed, 27 (54%)
strains had detectable FAME activity. Bovine mastitis
isolates of Escherichia coli and Streptococcus uberis
did not produce detectable FAME activity over 24 h
of growth. All S. aureus strains surveyed except one
produced detectable FAME activity (Table 1).
Different S. aureus strains exhibited different patterns
of FAME activity. In the laboratory strain S. aureus
RN6390, FAME activity increased with bacterial growth;
activity reached a plateau by 16 h at 5% esterification of
oleic acid to butyl oleate compared to a standard of
butyl stearate (FAME activity) per log CFU and
remained stable for the rest of stationary phase to 24 h
(Figure 2). Both S. aureus Newman and S. aureus
USA300 reached maximal FAME activity at 24 h (12.5%
and 21% FAME activity/log CFU, respectively). S. aureus
MN8 peaked at 16 h with 18% esterification per log
CFU. The bovine mastitis isolate S. aureus Novel
reached a maximum FAME activity of 7% esterification
per log CFU at 8 h, but the activity decreased at 20 h
with very little activity (0.7%) detected at 24 h. The other
bovine mastitis isolate tested, S. aureus Newbould 305,
did not have any detectable FAME activity over 24 h.
The pattern of FAME activity over a 24 h period exhib-
ited by CNS was different among species and strains
Table 1 FAME activity in tested bacteria








S. aureus 6 5 (83) 0–187*
Escherichia coli 2 0 (0) 0
Streptococcus uberis 1 0 (0) 0
Coagulase Negative Staphylococci
S. capitis 1 1 (100) 19–47*
S. caprae 3 3(100) 13–42*
S. chromogenes 15 4(27) 0–22*
S. epidermidis 2 2 (100) 4–6*
S. equorum 1 0 (0) 0
S. gallinarum 1 0 (0) 0
S. haemolyticus 8 4 (50) 0–21*
S. hominis 1 1 (100) 1–10*
S. hyicus 3 2 (67) 0–7*
S. sciuri 2 0 (0) 0
S. simulans 5 5 (100) 10–35*
S. succinus 2 1 (50) 0–5*
S. xylosus 6 4 (67) 0–172*
Total CNS 50 27 (54) 0–172
*Percent esterification compared to a standard with significant activity P< 0.05
from negative control.
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coccus capitis throughout its growth and peaked in sta-
tionary phase at 20 h (Figure 3). S. capitis produced
appreciable FAME activity from 16 to 24 h with 15%
esterification per log CFU at 20 h. By contrast, Staphylo-
coccus hominis FAME activity did not rise above 0.5% at
any point during the 24 h culture.Figure 2 Most surveyed S. aureus strains produce FAME activity. S. au
305 were assayed for FAME activity/log CFU over 24 h. CFUs were generall
phase indicated by the arrow. Results are the average of three experiments
bar is apparent the standard error is smaller than the symbol. Detectable a
8 h (P< 0.05).All Staphylococcus caprae strains examined started
producing FAME activity by 8 h (Figure 4). The three
strains reached a maximum activity by 16, 20, or 24 h.
The S. caprae strains surveyed had FAME activity peak-
ing around 1.7–5% by 24 h. Four out of 15 Staphylo-
coccus chromogenes strains produced FAME activity;
activity was greatest 20–24 h in culture (up to 2.7%
esterification) with one strain also producing some
activity (0.6% esterification per log CFU) from 4 to 8 h
(Figure 5). All Staphylococcus epidermidis (Figure 6)
strains surveyed produced increasing FAME activity up
to 20 h of culture with maximum activity less than 1%
esterification per log CFU. Four Staphylococcus haemoly-
ticus strains had no detectable FAME activity, however,
four other strains produced detectable FAME activity
beginning at 12 h (Figure 7). S. haemolyticus strains
exhibited considerable variation in the pattern of FAME
activity with maximal activity at different times of culture
and ranging from 2.5 to 8% (Figure 8). One strain of
Staphylococcus hyicus produced less than 0.5% FAME ac-
tivity per log CFU over the entire growth period with just
above the detectable limit at 16 h, while another strain
produced a detectable amount of FAME activity at 4 h
with activity increasing after 16 h up to 1% at 24 h (Fig-
ure 8). The FAME producing strains of Staphylococcus
simulans showed several patterns of FAME activity
throughout culture (Figure 9). These S. simulans strains
started producing detectable FAME activity at 4 h. Two
strains produced relatively consistent FAME activity (1–
2%) between 4 and 24 h. Two other strains of S. simu-
lans had FAME activity increase above 3% between
12 or 16 h. One strain of S. simulans had peak FAME
activity of 6.8% at 20 h. At 24 h, FAME activity in
S. simulans strains ranged from 1 to 4%. One strain ofreus strains RN6390, Newman, USA300, MN8, Novel, and Newbould
y the same among the strains with the beginning of stationary
. Vertical bars represent standard error of the observation; if no
ctivity for RN6390, Newman, USA300, MN8, and Novel was seen at
Figure 3 S. aureus, S. capitis, and S. hominis exhibit different patterns FAME activity. S. aureus RN6390, S. capitis, and S. hominis were
assayed for FAME activity/log CFU over 24 h. CFUs were generally the same among the strains with the beginning of stationary phase indicated
by the arrow. Results are the average of three experiments. Vertical bars represent standard error of the observation; if no bar is apparent the
standard error is smaller than the symbol. Detectable activity for S. aureus and S. capitis was seen at 4 h and for S. hominis at 24 h (P< 0.05).
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detectable FAME activity at 8 h but activity never rose
above 0.1%. Staphylococcus xylosus was the CNS strain
which produced the most FAME activity. In the four
S. xylosus strains with FAME activity, activity was
detected at 20 h (Figure 11). At 24 h, FAME activity in
these S. xylosus strains ranged from 1.7 to 20% esterifica-
tion per log CFU.
Lipase activity per CFU was compared to FAME activ-
ity per CFU over 24 h in 27 CNS strains with FAME
activity. All CNS strains surveyed produced lipase acti-
vity. The strains showed decreased lipase activity
(7.11 ± 0.52 log of percent lipase activity divided by CFU;
mean ± SD) at 24 h compared to 0 h. CNS strains that
exhibited no detectable FAME activity produced a rangeFigure 4 S. caprae produces FAME activity during stationary phase. S
CFUs were generally the same among the strains with the beginning of sta
experiments. Vertical bars represent standard error of the observation; if no
Detectable activity for all S. caprae isolates was seen at 8 h (P< 0.05).of lipase activity (4.35 ± 4.81 log of percent lipase activity
divided by CFU; mean± SD). In strains that did produce
FAME activity, the relationship between FAME and lip-
ase activity was poor (r2 = 0.1) when activity for each
were considered at each individual time point. However,
the relationship of the mean FAME and lipase activities
of all CNS with FAME activity at each time point corre-
lated well (r2 = 0.92). Lipase activity per CFU decreased
over the 24 h growth period.
No clear relationship was observed between FAME
activity and somatic cell count (SCC) in milk for all
CNS strains at 24 h (Figure 12). CNS strains with FAME
activity less than 30%, 30–60%, and greater than 60%
had SCC (mean x 1,000 per mL± SD) of 331 ± 585.2,
1,010.1 ± 237.4, and 150.9 ± 175.8, respectively.. caprae isolates were assayed for FAME activity/log CFU over 24 h.
tionary phase indicated by the arrow. Results are the average of three
bar is apparent the standard error is smaller than the symbol.
Figure 5 S. chromogenes isolates exhibit different patterns of FAME activity. S. chromogenes isolates were assayed for FAME activity/log
CFU over 24 h. CFUs were generally the same among the strains with the beginning of stationary phase indicated by the arrow. Results are the
average of three experiments. Vertical bars represent standard error of the observation; if no bar is apparent the standard error is smaller than
the symbol. S. chromogenes isolates had detectable FAME activity at 24 h (P< 0.05).
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Staphylococcus aureus, S. epidermidis, and several other
staphylococcal species have been shown to possess
FAME activity [4], but this enzyme activity had not been
assayed over a 24 h growth period or in other bacteria.
We surveyed FAME activity in CNS isolated from
bovine milk, S. aureus clinical isolates, and E. coli and
S. uberis bovine mastitis isolates which served as nega-
tive controls and compared it to a laboratory strain of
S. aureus. Using a quantitative assay of FAME activity,
we found that the relative range of FAME activity varied
across and within staphylococcal species over a 24 h
growth period. No FAME activity was found in E. coli or
S. uberis. In S. aureus, the highest FAME activity was
found in strains originally isolated from human infec-
tions, S. aureus USA300, S. aureus MN8, and S. aureusFigure 6 Two S. epidermidis isolates increase FAME activity over 24 h
24 h. CFUs were generally the same among the strains with the beginning
three experiments. Vertical bars represent standard error of the observation
FAME activity for all S. epidermidis isolates was detected at 6 h (P< 0.05).Newman. S. aureus Novel and S. aureus Newbould 305,
bovine mastitis isolates which cause acute and chronic
disease respectively [6], produced different patterns of
FAME activity. There was also a difference in virulence
between strains of S. aureus differing in FAME activity
as tested in a murine model; S. aureus strains with
FAME activity were able to persist longer in intraperi-
toneal abscesses than strains that did not produce this
activity [1]. The differences in FAME activity observed
in S. aureus Novel and S. aureus Newbould 305 and the
severity of disease caused by each strain suggest that
FAME may play a role in modulating virulence in bovine
mastitis. Contrary to data collected by Long et al. [4],
we found that some S. haemolyticus strains produced
FAME activity. FAME activity varied in CNS; some did
not rise above ~10% esterification at any point during. S. epidermidis isolates were assayed for FAME activity/log CFU over
of stationary phase indicated by the arrow. Results are the average of
; if no bar is apparent the standard error is smaller than the symbol.
Figure 7 S. haemolyticus isolates exhibit different patterns of FAME activity. S. haemolyticus isolates were assayed for FAME activity/log
CFU over 24 h. CFUs were generally the same among the strains with the beginning of stationary phase indicated by the arrow. Results are the
average of three experiments. Vertical bars represent standard error of the observation; if no bar is apparent the standard error is smaller than
the symbol. FAME activity for all S. haemolyticus isolates was detected at 12 h (P< 0.05).
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amount or similar pattern of FAME activity like S. aur-
eus. There were others such as S. equorum, S. galli-
narum, and S. sciuri which produced no detectable
FAME activity. However, this may not indicate that these
species lack FAME activity, only that the isolates tested
did not produce this activity under our assay conditions.
For the FAME positive CNS strains, FAME production
peaked at different stages of growth. The discrepancy of
FAME activity between different strains as well as spe-
cies may be due to strain differences. The agr locus has
high genetic variability in Staphylococcus species which
would lead to a variation in regulation of any down-
stream staphylococcal products [7]. FAME activity has
been shown to be regulated by agr and sar, global regu-
lators known to modulate the production of virulenceFigure 8 S. hyicus produces low FAME activity over 24 h. S. hyicus isola
generally the same among the strains with the beginning of stationary pha
experiments. Vertical bars represent standard error of the observation; if no
Both isolates had detectable activity at 4 h (P< 0.05).factors such as exotoxins [8,9]. Other regulators may
also play a part in differences of FAME production in
each strain. S. aureus RN6390, for example, is a natural
deletion mutant of rsbU, a regulator of σB, which con-
trols bacterial response to acid stress [10]. The potential
of S. aureus and CNS to cause a variety of diseases sug-
gests a complex mechanism for pathogenesis which
includes the regulatory input of environmental and host
signals. The expression of staphylococcal virulence genes
in vivo may also depend on distinct host signals from
the target tissue [9]. Considering strain variability of agr
alone, every strain could regulate FAME differently. As a
result, FAME may not necessarily be produced by
Staphylococcus spp. at a particular time point or growth
condition. In our assay of several time points throughout
a 24 h growth period, we found several Staphylococcustes were assayed for FAME activity/log CFU over 24 h. CFUs were
se indicated by the arrow. Results are the average of three
bar is apparent the standard error is smaller than the symbol.
Figure 9 S. simulans isolates exhibit a range of patterns for FAME activity. S. simulans isolates were assayed for FAME activity/log CFU over
24 h. CFUs were generally the same among the strains with the beginning of stationary phase indicated by the arrow. Results are the average of
three experiments. Vertical bars represent standard error of the observation; if no bar is apparent the standard error is smaller than the symbol.
FAME activity for all S. simulans isolates was detected at 4 h (P< 0.05).
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points earlier than 24 h.
Lipase activity is produced by a group of enzymes
found in a wide number of both Gram-negative and
Gram-positive bacteria [11]. FAME has been hypothe-
sized to work in concert with lipase to modify antimicro-
bial fatty acids in the host [4]. Kapral et al. [3] noted
that FAME activity is optimal within abscesses at pH 6
while lipase activity was optimal at pH 8. But more
recent biochemical analyses reveal that some staphylo-
coccal lipases are active over a broad pH range including
pH 6 [11]. In our study, all strains observed with FAME
activity also exhibited lipase activity lending support
to this hypothesis that the presence of both these activ-
ities are required for fatty acid modification in the bac-
terial environment. We found however that CNS strainsFigure 10 S. succinus produces low FAME activity over 24 h. Two S. su
activity. The FAME producing strain is shown for FAME activity/log CFU ove
beginning of stationary phase indicated by the arrow. Results are the avera
observation; if no bar is apparent the standard error is smaller than the symwithout FAME activity also had lipase activity. These
bacteria were originally isolated from bovine milk where
lipids are abundant [12,13]. Although lipase liberates
potentially bactericidal fatty acids, the lipase-producing
bacteria in milk may not be lipolytically active because
most of the milk lipids are sequestered in fat globules
[27]. A small increase in free fatty acids, however,
is found in milk of cows with clinical mastitis [28]. Since
staphylococci produce several lipases of which only a
few have been characterized [11], the conditions in
milk may not be optimal for lipase production in
the CNS strains surveyed in this study. In CNS that
did produce FAME activity, lipase and FAME activity
per CFU decreased as bacterial growth progressed over
24 h although these enzyme activities increased in the
overall culture.ccinus isolates were assayed but only one had detectable FAME
r 24 h. CFUs were generally the same among the strains with the
ge of three experiments. Vertical bars represent standard error of the
bol. FAME activity for S. succinus was detected at 8 h (P< 0.05).
Figure 11 S. xylosus produces the highest FAME activity of all surveyed CNS strains. S. xylosus isolates were assayed for FAME activity/log
CFU over 24 h. CFUs were generally the same among the strains with the beginning of stationary phase indicated by the arrow. Results are the
average of three experiments. Vertical bars represent standard error of the observation; if no bar is apparent the standard error is smaller than the
symbol. S. xylosus isolates had detectable FAME activity at 20 h (P< 0.05).
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innate immune cells, such as neutrophils or polymor-
phonuclear leukocytes, to the site of inflammation [14].
Somatic cell count (SCC) in milk is used as a reliable
indicator of inflammation in the mammary gland since it
consists primarily of neutrophils and other leukocytes
[15]. Previous observations suggested that FAME had a
possible role in suppressing the host immune response
[2]. However staphylococci associated with lower SCC
varied in FAME production, and those with very highFigure 12 Staphylococci with FAME activity are compared to somatic
counts from the milk samples from which the CNS strains were isolated are
No clear relationship was observed between FAME activity and SCC in milksomatic cell counts (above 1,000,000 cells/mL) had less
than 60% FAME activity (Figure 12). This lack of asso-
ciation between FAME activity and SCC indicates that
FAME in CNS plays little role in modulating the
recruitment of immune cells but does not eliminate
other possible functions. Modification of host lipids can
also aid pathogenesis by disrupting host membranes,
interfering with host signaling, and providing nutrients
for the bacterium. In order to modify these lipids, patho-
gens can produce an array of enzymes that act on thesecell counts in milk from commercial dairy cows. Somatic cell
compared with FAME activity assayed from 24 h culture supernatants.
for all CNS strains (r2 = 0.01).
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immune evasion. Staphylococcal lipase decreases phago-
cytosis and intracellular killing by human granulocytes
[16]. These lipases may also be involved in liberating
host cell lipids for nutrient uptake [17]. Cholesterol is
the preferred substrate for FAME [1] thus previously
identified FAME negative bacteria could have been
incorrectly characterized due to current methods which
use butanol instead of cholesterol. Cholesterol can be
manipulated by pathogens to influence host cell mem-
brane fluidity, signaling pathways, and lipid raft compos-
ition. Helicobacter pylori modifies cholesterol to escape
the immune system by inhibiting phagocytosis and T-cell
activation [18]. Staphylococci may be using FAME for
immunomodulation in a similar way by altering choles-
terol homeostasis.
Bacteria with properties that make them impermeable
to these antimicrobial lipids, such as thicker cell walls,
may not require an enzyme like FAME [19]. However,
FAME activity has only been surveyed in staphylococcal
strains, E. coli, and S. uberis so it is unknown whether
FAME is also widely found among bacterial species or is
a uniquely staphylococcal enzyme. We have also shown
that an assessment of FAME activity cannot rely solely
on one time point since activity did not occur only dur-
ing the stationary growth phase. Instead, FAME activity
patterns vary across strains and species. To determine
if FAME is unique to staphylococci, a comprehensive
survey including more species and a variety of growth
conditions would be required.
Conclusions
Some staphylococcal species surveyed produced FAME
activity, but E. coli and S. uberis strains did not, suggest-
ing that FAME activity may be limited to some staphylo-
coccal species. For the FAME positive CNS strains,
FAME production peaked at different stages of growth.
The greatest FAME activity was found in strains origin-
ally isolated from human infections. S. aureus Novel, a
strain associated with acute disease, produced detectable
FAME activity while S. aureus Newbould 305, a strain of
chronic disease, did not. The severity of disease caused
by each of strain suggests that FAME may play a role in
modulating virulence in bovine mastitis. All FAME pro-
ducing CNS exhibited lipase activity which may indicate
that both these enzymes work in concert to alter fatty
acids in the bacterial environment.
Methods
Bacterial strains
The strains used in this study are listed in Table 2. The
CNS strains were initially isolated from milk samples
collected from cows with intramammary infection in
dairies in Idaho and Washington and identified by 16 Sribosomal DNA sequencing [11]. Each strain was
streaked on tryptic soy agar (TSA) from glycerol stocks
and incubated overnight at 37°C before inoculating into
3 mL tryptic soy broth (TSB) and grown in a shaker
incubator at 37°C and 250 rpm for 16 h. To determine
the growth of each strain, the 16 h culture was inocu-
lated into TSB at 1:100 in triplicate and grown at 37°C
with shaking at 250 rpm for 24 h. Every 2 h from 0 to
8 h and every 4 h from 8 to 24 h, growth of bacterial
culture was determined by assaying optical density (OD)
at 600 nm and by plating serial dilutions on TSA to
determine colony forming units (CFU) for each strain in
triplicate. Plates were incubated at 37°C for 15 h before
determining bacterial growth.
FAME activity assay
Bacterial cultures were pelleted at 12,000 x g for 2 min,
and supernatant was removed for analysis. Activity of
FAME was determined by combining 700 μL of 0.1 M
sodium phosphate buffer (pH=6) with 250 μL of culture
supernatant and 50 μL oleic acid (4 mg/mL butanol) and
incubating the solution for 20 min at 37°C with gentle
shaking at 100 rpm. The reaction was terminated imme-
diately by adding 19 mL chloroform:methanol (2:1 v/v).
An internal standard containing butyl stearate (100 μL
added from stock of 0.5 mg/mL of chloroform) was used
to quantify the amount of oleic acid esterified to butyl
oleate. Lipids were extracted using the Folch procedure
[24] and butyl esters quantified. Samples were analyzed
using gas chromatography (Agilent Technologies
6890 N GC, California) equipped with a 30 m x
0.25 mm with 0.15 μm film DB-17HT capillary column
(Agilent J&W Scientific, California) with programmed
temperature runs using hydrogen as the carrier gas. The
oven temperature was initially 100°C and then increased
1.5°C/min until 165°C and then held constant for
45 min. The temperature was then ramped at 30°C/min
until 350°C. Injection port temperature was at 200°C.
One μL of each sample was injected and the split ratio
was 5:1 with flow rate held constant at 5 mL/min. Butyl
oleate and butyl stearate (internal standard) peaks were
detected with a flame ionization detector identified using
standards and the area of the peaks quantified and used
to calculate the percent of oleic acid esterified in each
sample. Controls included TSB with no added bacteria
in place of culture supernatant, and the phosphate buffer
alone plus butanol and oleic acid to ensure the product
did not form spontaneously.
Lipase assay
Lipase activity at each time point was determined by
adding 50 μl bacterial supernatant to 1 mL of lipase
assay reagent (10 mM para-nitrophenyl palmitate, 0.1%
Triton X-100 in ethanol) [25]. The reaction was
Table 2 List of strains used in this study
Species Strain Source or
reference
Escherichia coli TOP10 Invitrogen,
Carlsbad, CA
Escherichia coli ATCC25922 ATCC25922
Streptococcus uberis ATCC27958 ATCC27958
S. aureus RN6390 NCTC 8325-4*
S. aureus MN8 [20]*
S. aureus Newman [21]*
S. aureus USA300 [22]*
S. aureus Novel [23]
S. aureus Newbould 305 ATCC29740
S. capitis 240 [12]
S. caprae 21 [12]
S. caprae 208 [12]
S. caprae 253 [12]
S. chromogenes 1 [12]
S. chromogenes 14 [12]
S. chromogenes 61 [12]
S. chromogenes 68 [12]
S. chromogenes 74 [12]
S. chromogenes 100 [12]
S. chromogenes 105 [12]
S. chromogenes 111 [12]
S. chromogenes 133 [12]
S. chromogenes 136 [12]
S. chromogenes 159 [12]
S. chromogenes 184 [12]
S. chromogenes 207 [12]
S. chromogenes 232 [12]
S. chromogenes 267 [12]
S. epidermidis 28 [12]
S. epidermidis 35 [12]
S. equorum 117 [12]
S. gallinarum 196 [12]
S. haemolyticus 20 [12]
S. haemolyticus 39 [12]
S. haemolyticus 95 [12]
S. haemolyticus 98 [12]
S. haemolyticus 141 [12]
S. haemolyticus 180 [12]
S. haemolyticus 247 [12]
S. haemolyticus 275 [12]
S. hominis 260 [12]
S. hyicus 120 [12]
S. hyicus 154 [12]
Table 2 List of strains used in this study (Continued)
S. hyicus 155 [12]
S. sciuri 71 [12]
S. sciuri 99 [12]
S. simulans 23 [12]
S. simulans 112 [12]
S. simulans 125 [12]
S. simulans 181 [12]
S. simulans 250 [12]
S. succinus 261 [12]
S. succinus 110 [12]
S. xylosus 101 [12]
S. xylosus 113 [12]
S. xylosus 161 [12]
S. xylosus 183 [12]
S. xylosus 200 [12]
S. xylosus 246 [12]
*kindly supplied by Drs. G.A. Bohach and K.S. Seo (Mississippi State
University, Mississippi).
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measured at 405 nm on a Wallac Victor2 plate reader
(PerkinElmer, Turku, Finland). A standard curve was
developed using dilutions of a supernatant from a
S. aureus RN6390 24 h culture.
Somatic Cell Count
Milk samples at room temperature within 4 h post-
collection were used. SCC was determined in triplicate
using the DeLaval cell counter (DeLaval International
AB, Tumba, Sweden) [26]. A cassette containing propi-
dium iodide as the fluorescent stain was used to collect
60 μl milk. The sample was exposed to an LED light
source that causes the cell nuclei to give fluorescent
signals which were subsequently recorded as SCC in milk.
Statistics
Data were analyzed by Student’s t-test, SAS 9.2, to deter-
mine the threshold of FAME activity and lipase activity
compared with negative controls. Significant and detect-
able activity was declared when FAME or lipase activity
was different (P< 0.05) from both negative controls.
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